80 related articles for article (PubMed ID: 2453415)
1. Impaired ristocetin aggregation in myeloma due to binding of the aggregating agent by monoclonal protein--presentation of a case.
László E; Péterfy M; Puskás E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):852-6. PubMed ID: 2453415
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new mode of defective ristocetin-induced platelet aggregation.
Baugh RF; Hougie C
J Lab Clin Med; 1981 Jun; 97(6):864-80. PubMed ID: 6971912
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
4. A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder.
DiMinno G; Coraggio F; Cerbone AM; Capitanio AM; Manzo C; Spina M; Scarpato P; Dattoli GM; Mattioli PL; Mancini M
J Clin Invest; 1986 Jan; 77(1):157-64. PubMed ID: 2935559
[TBL] [Abstract][Full Text] [Related]
5. Proceedings: Two cases of von Willebrand's disease with specific inhibitors of ristocetin induced aggregation of normal platelets.
Blombäck M; Egberg N
Thromb Diath Haemorrh; 1975 Nov; 34(2):583. PubMed ID: 1081749
[No Abstract] [Full Text] [Related]
6. Plasma components which interfere with ristocetin-induced platelet aggregation.
Baugh RF; Brown JE; Hougie C
Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
8. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
9. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
[TBL] [Abstract][Full Text] [Related]
10. [Platelet aggregation caused by ristocetin--its implication and action mechanism].
Izuchi Y
Nihon Rinsho; 1978 Dec; 36(12):3848-56. PubMed ID: 372624
[No Abstract] [Full Text] [Related]
11. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to platelets.
Jenkins CS; Clemetson KJ; Lüscher EF
J Lab Clin Med; 1979 Feb; 93(2):220-31. PubMed ID: 311800
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
Jorieux S; de Romeuf C; Samor B; Goudemand M; Mazurier C
Thromb Haemost; 1987 Jun; 57(3):278-82. PubMed ID: 3116700
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
Ingalls CS; Somani P; Freimer EH
Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
[TBL] [Abstract][Full Text] [Related]
15. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
16. Effects of endothelin-1 on aggregation of normal and uremic platelets.
Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
[TBL] [Abstract][Full Text] [Related]
17. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
18. Defective platelet aggregation in myelodysplastic syndromes.
Girtovitis FI; Ntaios G; Papadopoulos A; Ioannidis G; Makris PE
Acta Haematol; 2007; 118(2):117-22. PubMed ID: 17726306
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
20. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
